Literature DB >> 9873726

Anthelmintic beta-hydroxyketoamides (BKAs).

B H Lee1, M F Clothier, F E Dutton, G A Conder, S S Johnson.   

Abstract

We have prepared several anthelmintic coumarins based on the beta-hydroxyketoamide (BKA) template and have shown that this template remains valid over a wide range of changes to the coumarin moiety allowing for the inclusion of carbocyclic, bicyclic, and heterocyclic rings.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9873726     DOI： 10.1016/s0960-894x(98)00588-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN： 0960-894X            Impact factor:   2.823


  5 in total

1.  Revisit to the synthesis of 1,2,3,4-tetrasubstituted pyrrole derivatives in lactic acid media as a green solvent and catalyst.

Authors:  Dilek Akbaslar; E Sultan Giray; Oztekin Algul
Journal:  Mol Divers       Date:  2020-09-27       Impact factor: 2.943

2.  Crystal structure of (6-bromo-2-oxo-2H-chromen-4-yl)methyl morpholine-4-carbodi-thio-ate.

Authors:  K Mahesh Kumar; K R Roopashree; M Vinduvahini; O Kotresh; H C Devarajegowda
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-06-13

3.  Functionalized 4-hydroxy coumarins: novel synthesis, crystal structure and DFT calculations.

Authors:  Valentina Stefanou; Dimitris Matiadis; Georgia Melagraki; Antreas Afantitis; Giorgos Athanasellis; Olga Igglessi-Markopoulou; Vickie McKee; John Markopoulos
Journal:  Molecules       Date:  2011-01-07       Impact factor: 4.411

4.  Pharmacological Evaluation and Docking Studies of 3-Thiadiazolyl- and Thioxo-1,2,4-triazolylcoumarin Derivatives as Cholinesterase Inhibitors.

Authors:  Ahsan Raza; Aamer Saeed; Aliya Ibrar; Muhammad Muddassar; Aftab Ahmed Khan; Jamshed Iqbal
Journal:  ISRN Pharmacol       Date:  2012-08-16

5.  Efficient one-pot synthesis, molecular docking and in silico ADME prediction of bis-(4-hydroxycoumarin-3-yl) methane derivatives as antileishmanial agents.

Authors:  Zahid Zaheer; Firoz A Kalam Khan; Jaiprakash N Sangshetti; Rajendra H Patil
Journal:  EXCLI J       Date:  2015-08-10       Impact factor: 4.068
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.